Third, patients with various types of liver disease, both acute and chronic, often develop complicating acid-base disturbances. In addition, liver disease may predispose the patient to a particular acid-base disorder such as phenformin-induced lactic acidosis. Finally, the acid-base disturbance may...
Third, patients with various types of liver disease, both acute and chronic, often develop complicating acid-base disturbances. In addition, liver disease may predispose the patient to a particular acid-base disorder such as phenformin-induced lactic acidosis. Finally, the acid-base disturbance may...
S-adenosylmethionine synthetase (SAMe) level is higher in the early stages of liver disease and leads to low methionine levels. However, SAMe level eventually decreases during the compensatory periods, and this in turn causes an increase in methionine levels during the liver failing process24. With...
Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. This study was conducted to validate a dynamic model of the stomach and small intestine to quantify the survival of lactic acid bacteria and to assess the ... P ...
Fig. 4. ABE in patients with chronic liver disease. a) ABE affecting factors in stable cirrhosis; b) Metabolic acidosis affecting factors in critical cirrhosis; c) Neutralisation of lactic acidosis by hypoalbuminemic alkalosis in acute liver failure. BE: Base excess; UMA: Unmeasured anions 1.4...
Chronic liver disease AFP: Alpha fetoprotein DCP: Des-gamma-carboxyprothrombin HIF-1α: Hypoxia-inducible factor 1 EpCAM ( +): Epithelial cell adhesion molecule PLA-PEG: Poly (lactic acid)-poly (ethylene glycol) References Chen F, Li Q, Xu X, Wang F. Clinical characteristics an...
Although further research is needed, correction of intestinal dysbiosis might be a novel therapeutic target to ameliorate the risk of NAFLD and chronic vascular complications of diabetes mellitus Abstract Nonalcoholic fatty liver disease (NAFLD) and diabetes mellitus are common diseases that often coexist...
Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to p... ...
Nonalcoholic fatty liver disease (NAFLD) is the most common noncommunicable chronic liver disease, with an estimated global prevalence of 24% and higher occurrence rates in South America and the Mi...
d-Glucose is a carbon unit for hepatic de novo lipogenesis and thereby contributes to nonalcoholic fatty liver disease and provides energy (25). Maltose, similar to d-glucose, is generated in the gut during starch digestion as a carbon transfer molecule and energy reserve (26), and its role...